E. Ribi

3.3k total citations
89 papers, 2.5k citations indexed

About

E. Ribi is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, E. Ribi has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 20 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in E. Ribi's work include Immune Response and Inflammation (20 papers), Tuberculosis Research and Epidemiology (17 papers) and Mycobacterium research and diagnosis (16 papers). E. Ribi is often cited by papers focused on Immune Response and Inflammation (20 papers), Tuberculosis Research and Epidemiology (17 papers) and Mycobacterium research and diagnosis (16 papers). E. Ribi collaborates with scholars based in United States, Germany and Japan. E. Ribi's co-authors include N Qureshi, Koichi Takayama, R. L. Anacker, K. C. Milner, Jon A. Rudbach, W. T. Haskins, W Brehmer, John L. Cantrell, J. E. Peterson and William R. Barclay and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

E. Ribi

87 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Ribi United States 29 1.3k 738 448 429 204 89 2.5k
Edgar Ribi United States 28 957 0.7× 662 0.9× 373 0.8× 373 0.9× 192 0.9× 66 2.2k
Maurice Landy United States 31 1.2k 0.9× 557 0.8× 318 0.7× 326 0.8× 251 1.2× 78 2.7k
S Kotani Japan 31 1.2k 0.9× 869 1.2× 354 0.8× 182 0.4× 484 2.4× 113 2.5k
M Parant France 30 1.5k 1.1× 800 1.1× 483 1.1× 281 0.7× 566 2.8× 107 2.7k
Louis Pillemer United States 28 1.1k 0.8× 552 0.7× 274 0.6× 226 0.5× 166 0.8× 54 2.7k
Aldo Tagliabue Italy 36 2.3k 1.7× 885 1.2× 487 1.1× 375 0.9× 345 1.7× 131 3.9k
J. G. Howard United Kingdom 33 1.2k 0.9× 444 0.6× 561 1.3× 140 0.3× 106 0.5× 82 2.6k
Alfred J. Crowle United States 29 1.1k 0.8× 683 0.9× 1.2k 2.6× 1.3k 2.9× 139 0.7× 125 3.3k
K. C. Milner United States 26 734 0.5× 503 0.7× 208 0.5× 191 0.4× 212 1.0× 55 1.8k
Benjamin Prescott United States 36 1.9k 1.4× 757 1.0× 1.1k 2.4× 340 0.8× 620 3.0× 125 3.7k

Countries citing papers authored by E. Ribi

Since Specialization
Citations

This map shows the geographic impact of E. Ribi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ribi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ribi more than expected).

Fields of papers citing papers by E. Ribi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ribi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ribi. The network helps show where E. Ribi may publish in the future.

Co-authorship network of co-authors of E. Ribi

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ribi. A scholar is included among the top collaborators of E. Ribi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ribi. E. Ribi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madonna, G S, et al.. (1988). Monophosphoryl lipid a and trehalose dimycolate therapy enhances survival in sublethally irradiated mice challenged with klebsiella pneumoniae. 351–356. 3 indexed citations
2.
Holmes, C. J., et al.. (1986). Effect of monophosphoryl lipid A on host resistance to bacterial infection. Infection and Immunity. 53(3). 711–712. 39 indexed citations
3.
Brehmer, W, et al.. (1984). Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.. PubMed. 3(6). 663–71. 12 indexed citations
4.
Takayama, Koichi, N Qureshi, C R Raetz, et al.. (1984). Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infection and Immunity. 45(2). 350–355. 94 indexed citations
5.
Ribi, E., Donald L. Granger, K. C. Milner, et al.. (1982). Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie. 251(3). 345–356. 17 indexed citations
6.
Ribi, E., R. Toubiana, S. Michael Strain, et al.. (1978). Further studies on the structural requirements of agents for immunotherapy of the guinea pig line-10 tumor. Cancer Immunology Immunotherapy. 3(3). 12 indexed citations
7.
Harris, Steven C., et al.. (1978). Bacillus Calmette-Guérin cell wall immunotherapy of intramuscular and metastatic Morris rat hepatomas.. PubMed. 38(5). 1217–22. 2 indexed citations
8.
Strain, S. Michael, Mayer B. Goren, Ichiro Azuma, et al.. (1978). Regression of line-10 hepatocellular carcinomas following treatment with water-soluble, microbial extracts combined with trehalose or arabinose mycolates. Cancer Immunology Immunotherapy. 4(1). 11 indexed citations
9.
Granger, Donald L., et al.. (1976). Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy. Infection and Immunity. 13(2). 543–553. 9 indexed citations
10.
Meyer, Thomas J., Ichiro Azuma, & E. Ribi. (1975). Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.. PubMed. 28(2). 219–29. 12 indexed citations
11.
Ribi, E., Ichiro Azuma, Thomas J. Meyer, et al.. (1974). [Chemical structures and biological functions of mycobacterial cell walls with special reference to immunity against airborne infection by the strain M. tuberculosis H37Rv].. PubMed. 49(1). 366–77. 1 indexed citations
12.
Ribi, E., et al.. (1973). Purification of Δ9-Tetrahydrocannabinol, an Active Constituent of Marihuana, by Accelerated Microparticulate Gel Chromatography. Preparative Biochemistry. 3(3). 209–220. 2 indexed citations
13.
Ribi, E., R. L. Anacker, William R. Barclay, et al.. (1968). STRUCTURE AND BIOLOGICAL FUNCTIONS OF MYCOBACTERIA. Annals of the New York Academy of Sciences. 154(1). 41–57. 9 indexed citations
14.
Weibull, Claes, et al.. (1967). Chemical, Biological, and Structural Properties of StableProteusL Forms and Their Parent Bacteria. Journal of Bacteriology. 93(3). 1143–1159. 25 indexed citations
15.
Haskins, W. T., et al.. (1966). Determination of heptose in endotoxins. Journal of Bacteriology. 92(1). 284–284. 1 indexed citations
16.
Anacker, R. L., et al.. (1966). Frequency of Occurrence of Native Hapten Among Enterobacterial Species. Journal of Bacteriology. 91(4). 1427–1433. 23 indexed citations
17.
Rudbach, Jon A., E. Ribi, & K. C. Milner. (1965). Reactivation of Papain-Treated Endotoxin. Experimental Biology and Medicine. 119(1). 115–118. 5 indexed citations
18.
Anacker, R. L., R. A. Finkelstein, W. T. Haskins, et al.. (1964). ORIGIN AND PROPERTIES OF NATURALLY OCCURRING HAPTEN FROMESCHERICHIA COLI. Journal of Bacteriology. 88(6). 1705–1720. 38 indexed citations
19.
Larson, C. L., et al.. (1963). Resistance to Tuberculosis in Mice immunized with BCG disrupted in Oil. Nature. 198(4886). 1214–1215. 12 indexed citations
20.
Ribi, E.. (1953). Electron microscopic investigation of the cell wall organization of wood. Experimental Cell Research. 5(1). 161–172. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026